4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-22-019753
Director bought 317,460 shares at $3.15 ($999,999)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamilton Thomas Edward Director | 2022-09-16 | Purchase | +317,460 | $3.15 | $999,999 | 507,590 | D: show line 1 in the form |
| Open-market purchases · 317,460 sh · avg $3.15 · $999,999 | |||||||
Loading xslF345X03/form4.xml…